<DOC>
	<DOCNO>NCT01681407</DOCNO>
	<brief_summary>A pilot study map peripheral plasma micro-RNA proteomics pattern depressive patient , treat SSRI medication . It observational clinical bio-markers laboratory control research device . The research include two group ; one patient diagnosed depression , get standard SSRI medication regimen . Second group control subject without depression . An option third group plan include first degree relative depress patient . After give informed consent , subject patient go standard clinical psychiatric interview , routine clinical lab test . Clinical standard , specific depression anxiety questionnaire hold four follow-up meeting : start ; 2 week ; 4 week ; 10 week . Subjects patient ask give blood sample point time lab processing : Complete plasma proteomics specific micro-RNA level .</brief_summary>
	<brief_title>Peripheral Plasma Micro-RNA Proteomics Mapping Depressive Patients , Treated With SSRI Medications</brief_title>
	<detailed_description />
	<mesh_term>Depression</mesh_term>
	<mesh_term>Serotonin Uptake Inhibitors</mesh_term>
	<criteria>Depressed patient , 18 yo Untreated SSRI , last 3 month Bipolar patient another major psychopathology Depressive disorder clearly due general medical condition , drug relate BMI 18.5 40 Pregnant patient Active suicidality</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2015</verification_date>
	<keyword>Depression</keyword>
	<keyword>Selective Serotonin Reuptake Inhibitors</keyword>
	<keyword>MicroRNAs</keyword>
	<keyword>Proteome</keyword>
</DOC>